María José Alonso’s lab has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. She has participated in 16 international projects. She is the author of 310 scientific contributions with more than 40,000 cites (H factor 104) and the inventor of 23 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010) and she is on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals (The Medicine Maker, 2020-21). She was former President of the Controlled Release Society and she is currently Editor-in-Chief of the Drug Delivery and Translational Research. In 2006-10, she was the Vice-rector of Research and Innovation of the USC. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and of the Controlled Release Society (CRS), a member of three Academies in Spain, a member of the US National Academy of Medicine (NAM) and a member of the Royal Academy of Medicine of Belgium. She received the National Sciences Award ‘Juan de la Cierva’, the most prestigious award given to Spanish Scientists.